Submit your Serzone claim details for a free, no obligation case review
Get Started:
There have been many different class action lawsuits filed for the serious adverse effects that pharmaceutical medications have caused in the past. A Serzone class action lawsuit was recently filed against Serzone manufacturer Bristol-Myers Squibb Company. The antidepressant drug was first approved in December 1994 and has been linked to cases of liver failure and other serious conditions. Class action lawsuits are sometimes unable to cover the extensive injuries that require a larger sum of monetary compensation, but our team of experienced, expert Serzone lawyers can take individual claims to help recover the proper compensation for the injuries you have suffered.
During the period of 1996 to June 2000 there were eighteen cases of reported Serzone liver failures. Bristol-Myers promised to research the effect of Serzone use on younger patients and to report the results to the FDA, but so far no results have been provided. The Serzone manufacturer did say they hoped to report results to the FDA in the early part of 2002, which would be about seven years after the FDA approval. Serzone is currently prescribed to young patients despite the fact that when Serzone was FDA approved the administration knew that children and adolescents were not safe using the antidepressant.
Clinical trials prior to Serzone''s FDA approval showed other Serzone side effects. These side effects included, dry mouth, drowsiness, nausea, dizziness, constipation, weakness, lightheadedness, blurred vision, confusion, and abnormal vision. Serzone was also possibly linked to hypomania, a mood swing that ranges from euphoria, racing thoughts, pressured speech, and excessive energy.
Drug manufacturer Bristol-Meyers announced Wednesday that it will no longer make or sell Serzone, an antidepressant that has been linked to potentially deadly liver complications and has already been withdrawn in major markets including Europe and Can...
Public Citizen has sued the FDA, calling the agency "grossly negligent" for failing to issue a Serzone ban despite having already been taken off the market in Canada and Europe, with sales to end in Australia and New Zealand in May. The consumer watchd...
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice